Bifogade filer
Vimian Q3 Report
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Strengthened market positions in challenging macroeconomy
- Revenue increased by 70.9 per cent to EUR 70.9m (41.5), of which 5.2 per cent was organic growth (8.3 per cent excluding Diagnostics)
- Adjusted EBITA EUR 17.2m (11.6), corresponding to an adjusted EBITA margin of 24.3 per cent (27.9)
- Operating profit totalled EUR 8.8m (4.5), including items affecting comparability of EUR -3.6m (-4.0). Profit for the quarter totalled EUR 1.6m (-0.3)
- Earnings per share before dilution EUR -0.00 (-0.00) and after dilution EUR 0.00 (-0.00)
“In the third quarter, we strengthened our global market positions in a turbulent macroeconomic environment. Total revenue grew by 70.9 per cent to EUR 70.9 million, with an adjusted EBITA margin of 24.3 per cent reflecting consolidation of acquired companies. Our companion animal businesses delivered solid 8.3 per cent organic growth in the third quarter and 9.5 per cent for the full nine months period”, says Dr. Fredrik Ullman, CEO of Vimian Group.
Last twelve months pro-forma revenues (including the full year impact of all acquisitions completed during the twelve months ending 30 September) reached EUR 288.4 million and pro-forma EBITDA EUR 82.7 million.
“We continued our journey building a global, leading animal health company and reached pro-forma revenues of EUR 288.4 million with an adjusted EBITDA of EUR 82.7 million for the past twelve months. In October, we successfully completed a SEK 1.5 billion capital raise to finance strategic acquisitions and reduce indebtedness”, says Dr. Fredrik Ullman, CEO of Vimian Group.
A telephone and web conference will be held for investors, analysts, and media, today at 09.00 (CET). The conference will be held in English and include a question-and-answer session.
To attend the telephone conference:
SE: +46 856642695
UK: UK +44 3333000804 (UK pin code: 61572279#)
US: +1 6467224956
To attend the webcast:
Link: https://ir.financialhearings.com/vimian-group-q3-2022
Related presentation materials will be available on Vimian’s website (https://vimian.com/investors/reports-and-presentations/) ahead of the telephone and web conference.